Navigation Links
Johnson Health Tech Statement on Lance Armstrong
Date:8/24/2012

COTTAGE GROVE, Wis., Aug. 24, 2012 /PRNewswire/ -- In light of the recent developments between the United States Anti-Doping Agency (USADA) and Lance Armstrong, Johnson Health Tech (JHT) reaffirms our support of Armstrong and the Lance Armstrong Foundation. JHT fully supports the great work they do helping families throughout the world overcome cancer's financial, practical and emotional challenges. With each purchase from our LIVESTRONG line of fitness equipment, a donation is made toward their cause. We look forward to continuing our support of Armstrong and the Foundation as they work tirelessly to support people and families affected by cancer, especially those in underserved communities.


'/>"/>
SOURCE Johnson Health Tech North America
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. EFJohnson Announces Impact Partner Dealer Program
2. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
3. Johnson & Johnson Provides Notice Of Proposed Settlement Of Shareholder Derivative Actions, Final Settlement Hearing, And Right To Appear
4. GHX CEO Bruce Johnson Recognized as Ernst & Young Rocky Mountain Region Entrepreneur of the Year 2012
5. Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results
6. N.J. Woman Sues Johnson & Johnsons Ethicon Unit Over Vaginal Mesh Injuries, Says The Lanier Law Firm
7. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
8. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
9. Depomed To Present At Stifel Nicolaus 2012 Healthcare Conference
10. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
11. Alimera Sciences To Present At 2012 Stifel Nicolaus Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology:
(Date:9/21/2017)... ... September 21, 2017 , ... Japanese Zen artist couple, Fumie ... on 6th, 7th and 8th October at Miranda Kuo Gallery on Lower East Side, ... such as Zen Kodo mat. Wanderlust , one of the largest US yoga ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... of the Month, Lewis and Clark College Emeritus Professor of Education Gregory A. ... Boninger, co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and the ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... of providing a voice for people who have kidney disease. The theme “Describe ... to share their stories. Entrants needed to meet only one qualification— to ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... the Orthodontics and Clear Aligner clinical and commercial support services market) has entered ... Dentistry (PGSD) in Sydney, Australia. , The PGSD is the first private ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... social campaign, “Humans With Vaginas.” The goal is to ignite conversation via social ... personal care products. The brand has declared September “Humans with Vaginas” month, releasing ...
Breaking Medicine News(10 mins):